As these models continue to advance, it is important to understand how their performance holds up over time.

This is despite experts cautioning that these findings should be "systematically and fully assessed" due to their progressive nature.

Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

A new analysis in JACR estimates that spotting the signs of a previously undetected stroke could benefit up to 200,000 people in the United States every year.

“When we rely too much on whatever the computer tells us, that’s a problem."

By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.

The hope is that by creating detectors that are more sensitive, less ionizing radiation will be needed to produce diagnostic quality imaging.

A new analysis in Academic Radiology dives into the importance of finding balance between reducing radiation exposure while maintaining image quality. 

A recent analysis of an already CE-marked, AI-based system that identifies pneumothorax on chest radiographs revealed a weak point in what has largely been considered a reliable support tool. 

The software is the first of its kind to achieve the FDA's approval for detecting, measuring and grading ARIA on MRI scans—a task that is critical in managing the disease.